Navigation Links
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Date:5/30/2008

for an increase in the dose of, or initiation of, insulin and/or oral hypoglycemic agent therapy and/or lipid-lowering agents, respectively.

The use of TORISEL may result in immunosuppression. Patients should be carefully observed for the occurrence of infections, including opportunistic infections. Cases of interstitial lung disease, some resulting in death, have occurred. Some patients were asymptomatic and others presented with symptoms. Some patients required discontinuation of TORISEL and/or treatment with corticosteroids and/or antibiotics. Cases of fatal bowel perforation occurred with TORISEL. These patients presented with fever, abdominal pain, metabolic acidosis, bloody stools, diarrhea, and/or acute abdomen. Cases of rapidly progressive and sometimes fatal acute renal failure not clearly related to disease progression occurred in patients who received TORISEL.

Due to abnormal wound healing, use TORISEL with caution in the perioperative period. Patients with central nervous system tumors (primary CNS tumor or metastases) and/or receiving anticoagulation therapy may be at an increased risk of developing intracerebral bleeding (including fatal outcomes) while receiving TORISEL. Live vaccinations and close contact with those who received live vaccines should be avoided. Patients and their partners should be advised to avoid pregnancy throughout treatment and for 3 months after TORISEL therapy has stopped.

The most common (incidence greater than or equal to 30%) adverse reactions observed with TORISEL are: rash (47%), asthenia (51%), mucositis (41%), nausea (37%), edema (35%), and anorexia (32%). The most common laboratory abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%).
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
2. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
3. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
4. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
5. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
9. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
10. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Pa. , June 2, 2015 Today ...  build three new distribution centers in Olive ... ; and Newburgh, NY . The ... company,s ability to improve product access, increase supply chain ... announcement is part of the company,s ongoing investments, more ...
(Date:6/2/2015)... Calif. , June 2, 2015  Accuray Incorporated ... team is scheduled to present at the Goldman Sachs ... Palos Verdes, California on Wednesday, June 10, ... webcast of the presentation will be available on the ... http://www.accuray.com/investors .  The webcast replay of the presentation will ...
(Date:6/2/2015)... BOSTON , June 2, 2015  Ovatemp proudly ... their fertility throughout their entire reproductive life cycle, from ... with the ONDO Bluetooth basal thermometer and connected Ovatemp ... odds of getting pregnant, or avoid pregnancy altogether. The ... and the free Ovatemp app can be downloaded from ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Techstars-backed Startup Ovatemp Launches the Only Complete, Personalized Fertility Management Platform for Women 2
... Data from experimental work on the use,of ... this week at the,International Society for Heart and ... donors after cardiac death,(DCD), also known as non-heart-beating ... shortage of suitable donor organs for lung, and,possibly ...
... Institute,s NABTT ... Consortium -, ... expansion of the clinical program for the company,s lead,product candidate, BSI-201, ... first poly ADP-ribose polymerase,(PARP) inhibitor in BiPar,s DNA repair portfolio, crosses ...
Cached Medicine Technology:Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 2Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
(Date:6/2/2015)... DuPont Pioneer , one of the world’s ... and office facility in Zambia that will increase maize ... and export markets to Kenya, Tanzania and other markets ... breadbasket for southern Africa provided an enabling agricultural environment ... Africa senior business manager of DuPont Pioneer “Our aim ...
(Date:6/2/2015)... 02, 2015 ODU , ... performance connector solutions and cable assemblies, is announcing ... to the US market. , ODU MINI-SNAP® ... capabilities. The self- securing circular connector solution is ... that require significant customization such as: sensor devices, ...
(Date:6/2/2015)... PhishLine, LLC today announced it ... Drive, Suite 125 in Waukesha, Wisconsin 53186. ... base of operations for PhishLine’s current corporate staff ... , Mark Chapman, Founder and President, commented “PhishLine ... enterprise customers adopt our market leading service to ...
(Date:6/2/2015)... 02, 2015 The Non-GMO Project ... products made according to rigorous best practices for ... produced in compliance with the Non-GMO Project Standard ... risk ingredients, facility inspections and an annual audit ... avoidance. , “Savoury Systems is and has always ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 TheCelebrityDresses.com, a ... announced big discounts on their summer fashion cocktail dresses. ... and short dresses that would be suitable for a ... parties. , TheCelebrityDresses.com designs and make high quality ... fabrics they use include high quality satin, chiffon and ...
Breaking Medicine News(10 mins):Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:PhishLine, LLC Announces New Corporate Headquarters 2Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2
... in preventing colorectal tumors in two mouse models of the ... The findings are published in the November issue of ... third most common cancer and the second leading cause of ... according to the National Cancer Institute. Building on previous ...
... 2 (HealthDay News) -- A patient-tailored fall prevention program ... patients, a new study reports. Hospital patients are ... and being in an unfamiliar environment. Falls and fall-related ... care workers and the health care system, according to ...
... -- A certain area of the cerebral cortex is thinner ... a new study. The cerebral cortex is an area ... impulse control and decision making. German researchers obtained high-resolution ... 21 people who never smoked. Using these images, the scientists ...
... a condition that may be responsible for up to ... to one-fifth of all cases of blood clots in ... few randomized clinical trials have been conducted involving people ... of participants. To stimulate an international discussion on ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Certain ... people with chronic obstructive pulmonary disorder (COPD), which includes ... For the study, 20 COPD patients (13 women, seven ... of vitamins A, C, D, E and selenium, all ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Extroverts are ... had lots of social activity than after they,ve been alone, ... (outgoing, unreserved folks) and 25 introverts (reserved, shy types), aged ... "socially enriched group" or a "socially impoverished group." Those ...
Cached Medicine News:Health News:Black raspberries may prevent colon cancer, study finds 2Health News:Program May Help Prevent Falls in Hospitalized Patients 2Health News:International summit held to stimulate collaborative clinical research on antiphospholipid syndrome 2Health News:Poor Diet May Make COPD Worse, Study Finds 2Health News:Socializing Tied to Sleep Deprivation in Extroverts 2
... easy-to-operate, semi-automatic urine analyzer that ensures accurate ... lab efficiency by reducing "hands on" operator ... it an ideal fit for work areas ... II Analyzer is designed for continuous sample ...
Ad-Techs Epidural Peg Electrodes feature a silicone-insulated titanium contact. To accommodate varying skull thicknesses, the post lengths range in length from 4 to 16 mm. The connecting lead wires e...
...
... Junior II is a ... for standardised reflectance photometric ... software features allow user ... and convenience to supply ...
Medicine Products: